You might also be interested in:

Moritz Grossmann congratulates the New England Patriots with the SUPERBOWL watch

Glashütte (ots) - Loved by some, feared by others. There is no club where hearts and minds are as divided as ...

Germany Sees Red: Eon Becoming a New Energy Monopoly

Hamburg (ots) - - Crossreference: Picture is available at http://www.presseportal.de/bilder - Analysis ...

InnoGames boosts mobile revenues by 37 percent in 2018 / Online game developer and publisher reports double-digit percentage revenue growth in its 12th year on the market

Hamburg (ots) - InnoGames, Germany's leading developer and publisher of mobile and online games, today published ...

05.02.2019 – 17:15

Marinomed Biotech AG

EANS-Voting Rights: Marinomed Biotech AG
Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc with the aim of a
  Europe-wide distribution. The issuer is responsible for the content of this
  announcement.
--------------------------------------------------------------------------------


      Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018
                                                                  Wien, 4.2.2019
Overview
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Other
3. Person subject to notification obligation
Andreas Grassauer
4. Name of shareholder(s):
5. Date on which the threshold was crossed or reached: 1.2.2019
6. Total positions
 ______________________________________________________________________________
|               |               |  % of voting  |              |               |
|               |  % of voting  |rights through |Total of both |Total number of|
|               |rights attached|financial/other| in % (7.A +  | voting rights |
|               |to shares (7.A)| instruments   |     7.B)     |   of issuer   |
|_______________|_______________|(7.B.1_+_7.B.2)|______________|_______________|
|   Resulting   |               |               |              |               |
| situation on  |               |               |              |               |
|  the date on  |    10,15 %    |    0,00 %     |   10,15 %    |   1 260 000   |
|which threshold|               |               |              |               |
| was crossed / |               |               |              |               |
|____reached____|_______________|_______________|______________|_______________|
|  Position of  |               |               |              |               |
|   previous    |    10,15 %    |               |   10,15 %    |               |
| notification  |               |               |              |               |
|(if_applicable)|_______________|_______________|______________|_______________|


Details
7. Notified details of the resulting situation:
 ______________________________________________________________________________
|A:_Voting_rights_attached_to_shares___________________________________________|
|             |____Number_of_voting_rights____|_______%_of_voting_rights_______|
|             |    Direct     |   Indirect    |    Direct     |    Indirect    |
|  ISIN Code  |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG |
|_____________|_____2018)_____|_____2018)_____|_____2018)_____|_____2018)______|
|ATMARINOMED6_|________127_841|_______________|________10,15_%|________________|
|_SUBTOTAL_A__|____________127_841____________|____________10,15_%_____________|

 ______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG  |
|2018__________________________________________________________________________|
|             |               |               |Number of voting |              |
|             |               |               | rights that may |              |
|   Type of   |               |               |       be        | % of voting  |
| instrument  |Expiration Date|Exercise Period|acquired if the  |    rights    |
|             |               |               |  instrument is  |              |
|_____________|_______________|_______________|____exercised____|______________|
|_____________|_______________|_SUBTOTAL_B.1__|_________________|______________|

 _____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018_________________________________________________________________________|
|  Type of  | Expiration | Exercise  | Physical /  | Number of   |% of voting |
|instrument |    Date    |  Period   |    Cash     |voting rights|   rights   |
|___________|____________|___________|_Settlement__|_____________|____________|
|___________|____________|___________|SUBTOTAL_B.2_|_____________|____________|


8. Information in relation to the person subject to the notification obligation:
Person subject to the notification obligation is not controlled by any natural
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuer.
9. In case of proxy voting
Date of general meeting: -
Voting rights after general meeting: - is equivalent to - voting rights.
10. Sonstige Kommentare:
Erstmeldung wegen IPO
Wien am 4.2.2019


end of announcement                         euro adhoc
--------------------------------------------------------------------------------



issuer:       Marinomed Biotech AG
              Veterinärplatz 1
              A-1210 Wien
phone:        0043250774460
FAX:          0043250774493
mail:      office@marinomed.com
WWW:       www.marinomed.com
ISIN:         ATMARINOMED6, AT0000A1WD52
indexes:      
stockmarkets: Wien
language:     English
 

Original content of: Marinomed Biotech AG, transmitted by news aktuell

All Releases
Subscribe to Marinomed Biotech AG
  • Printable version
  • PDF version

Places in this release

Topics in this relase